Defensins and Lung Function in Smokers
Author Information
Author(s): Wallace Alison M, He Jian-Qing, Burkett Kelly M, Ruan Jian, Connett John E, Anthonisen Nicholas R, Paré Peter D, Sandford Andrew J
Primary Institution: University of British Columbia
Hypothesis
Do alpha-defensin and beta-defensin polymorphisms influence smokers' susceptibility to lung function decline and lower respiratory infections?
Conclusion
In a white population, the tested defensin polymorphisms do not significantly influence lung function decline or susceptibility to lower respiratory infections.
Supporting Evidence
- The study involved 579 smokers, with 275 showing fast lung function decline and 304 showing no decline.
- No significant associations were found between the tested polymorphisms and lung function decline.
- The study's findings suggest that defensin polymorphisms may not be important predictors of lung health in smokers.
Takeaway
The study looked at whether certain genes related to immune response affect lung health in smokers, and found that they don't seem to make a difference.
Methodology
Participants were genotyped for specific defensin polymorphisms and their lung function was assessed over five years.
Potential Biases
Potential population stratification could influence results, but was not fully addressed.
Limitations
The study only examined a few polymorphisms and focused on a specific racial group, which may limit the generalizability of the findings.
Participant Demographics
579 white and non-Hispanic smokers, aged 35-60, with mild to moderate airflow obstruction.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website